Deferoxamine reduces tissue injury and lethality in LPS-treated mice
- 1 August 2000
- journal article
- Published by Elsevier BV in International Journal of Immunopharmacology
- Vol. 22 (8), 635-644
- https://doi.org/10.1016/s0192-0561(00)00026-6
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- Hydroxyl radical scavengers inhibit TNF-α production in mononuclear cells but not in polymorphonuclear leukocytesInternational Journal of Immunopharmacology, 1998
- Xanthine oxidase activity and free radical generation in patients with sepsis syndromeCritical Care Medicine, 1996
- Decreased antioxidant status and increased lipid peroxidation in patients with septic shock and secondary organ dysfunctionCritical Care Medicine, 1995
- Initial evaluation of human recombinant interleukin-1 receptor antagonist in the treatment of sepsis syndrome: A randomized, open-label, placebocontrolled multicenter trialCritical Care Medicine, 1994
- The Pathophysiology of Tumor Necrosis FactorsAnnual Review of Immunology, 1992
- The Biology of Cachectin/TNF -- A Primary Mediator of the Host ResponseAnnual Review of Immunology, 1989
- Tumor necrosis factor provokes superoxide anion generation from neutrophilsBiochemical and Biophysical Research Communications, 1986
- Modulation of endothelial cell hemostatic properties by tumor necrosis factor.The Journal of Experimental Medicine, 1986
- Molecular Cloning of the Complementary DNA for Human Tumor Necrosis FactorScience, 1985
- Treatment of Gram-Negative Bacteremia and Shock with Human Antiserum to a MutantEscherichia coliThe New England Journal of Medicine, 1982